Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Novo Nordisk
Novo Nordisk
Novo Nordisk says Wegovy can help heart disease patients—and not just because it produces weight loss
Fierce Pharma
Mon, 11/13/23 - 12:08 pm
Novo Nordisk
Wegovy
heart disease
cardiovascular disease
clinical trials
Wegovy cuts risk of heart attacks in milestone cardiovascular trial
Stat
Sun, 11/12/23 - 09:32 pm
Wegovy
Novo Nordisk
clinical trials
cardiovascular disease
Lilly’s Zepbound vs. Novo’s Wegovy: The Weight-Loss Drug Race Has Officially Started
Motley Fool
Sun, 11/12/23 - 09:21 pm
Eli Lilly
Zepbound
Novo Nordisk
Wegovy
weightloss
Novo Nordisk sets aside $6bn to boost production capacity
Pharmaphorum
Fri, 11/10/23 - 10:11 am
Novo Nordisk
diabetes
obesity
drug manufacturing
Senator floats new models to manage costs of weight loss drugs like Ozempic
Stat
Thu, 11/9/23 - 09:54 am
Novo Nordisk
Wegovy
Ozempic
weightloss
Senate
drug pricing
People Are Paying $25 for Wegovy, and It's Going to Keep Making Novo Nordisk Billions
Motley Fool
Thu, 11/9/23 - 09:53 am
Novo Nordisk
Wegovy
weightloss
Novo Nordisk to discontinue Levemir insulin in U.S. market
Reuters
Wed, 11/8/23 - 09:59 pm
Novo Nordisk
Levemir
insulin
diabetes
Novo Nordisk warns EU that new rules will push it to expand faster in US
Financial Times
Sun, 11/5/23 - 11:15 pm
Novo Nordisk
Europe
Novo, Lilly Weight-Loss Drug Juggernaut Has Nowhere to Go But Up
BioSpace
Sun, 11/5/23 - 11:12 pm
Novo Nordisk
Eli Lilly
Wegovy
Mounjaro
weightlosss
Novo Nordisk shrugs off supply issues with record sales
Pharmaphorum
Thu, 11/2/23 - 11:37 am
Novo Nordisk
Ozempic
earnings
Novo Nordisk is concluding research on Wegovy’s impact on osteoarthritis
Stat
Thu, 11/2/23 - 11:35 am
Novo Nordisk
Wegovy
osteoarthritis
Pfizer’s twice daily pill for obesity hopes to rival Wegovy and Mounjaro
Stat
Thu, 10/26/23 - 11:24 am
Pfizer
danuglipron
obesity
Wegovy
Mounjaro
Novo Nordisk
Demand for Ozempic and Wegovy Is Through the Roof. Here's Why it Can Go Even Higher.
Motley Fool
Wed, 10/25/23 - 09:51 am
Novo Nordisk
Ozempic
Wegovy
diabetes
weight loss
Belgium plans temporary ban on use of Ozempic for weight loss
Yahoo/Reuters
Tue, 10/24/23 - 09:39 am
Novo Nordisk
Ozempic
diabetes
weight loss
Belgium
drug shortages
NASH on the Cusp: An Emerging Market Opportunity
BioSpace
Mon, 10/23/23 - 09:53 am
NASH
Viking Therapeutics
Madrigal Pharmaceuticals
Terns Pharmaceuticals
Akero Therapeutics
Hepion Pharmaceuticals
Novo Nordisk
Galmed Pharmaceuticals
GE HealthCare, Novo Nordisk partner to treat diabetes and obesity with ultrasound
Mass Device
Fri, 10/20/23 - 10:14 am
Medtech
GE Healthcare
Novo Nordisk
PFUS
ultrasound
obesity
type 2 diabetes
Novo Nordisk, with coffers filling with cash, buys rival to Bayer's kidney drug Kerendia in $1.3B deal
Fierce Biotech
Mon, 10/16/23 - 10:24 am
Novo Nordisk
KBP Biosciences
Bayer
chronic kidney disease
Kerendia
ocedurenone
hypertension
High-flying Novo Nordisk once again dials up its 2023 sales and profit expectations
Fierce Pharma
Fri, 10/13/23 - 12:04 pm
Novo Nordisk
Ozempic
Wegovy
Fresenius Medical: effect of drugs like Ozempic on patient numbers is neutral
Yahoo/Reuters
Thu, 10/12/23 - 05:24 pm
Fresenius Medical Care
Ozempic
diabetes
weight loss
Novo Nordisk
dialysis
Medtech
Far More Employers Could Cover Weight Loss Drugs Like Wegovy Next Year—Here’s What That Means For Costs
Forbes
Thu, 10/12/23 - 11:40 am
weight loss
Ozempic
Wegovy
Novo Nordisk
Eli Lilly
Mounjaro
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »